SalvaRx Group's Reverse Merger Round

SalvaRx Group raised a round of funding on March 22, 2016. Investors include 3Legs Resources.

The SalvaRx Group is a drug discovery and development company focused on immune-oncology; SalvaRx invests in novel cancer immuno-therapies and provides its portfolio companies with operational support…

Articles about SalvaRx Group's Reverse Merger Round: